These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3970852)

  • 1. Plasma cell acid phosphatase score in multiple myeloma and related disorders.
    Hoffmann JJ; Breed WP; Swaak-Lammers N
    Br J Haematol; 1985 Jan; 59(1):67-72. PubMed ID: 3970852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
    Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies].
    Ricci C; Coscia GG; Bellone G; Novarini M; Discalzi GL; Cascio G
    Acta Med Austriaca; 1984; 11(2):37-43. PubMed ID: 6741437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G; Pirali F; Inzoli MR
    Minerva Med; 1981 Sep; 72(37):2479-83. PubMed ID: 7279268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymecytochemistry and immunohistochemistry in monoclonal gammopathy and reactive plasmacytosis.
    Johansen P; Jensen MK
    Acta Pathol Microbiol Scand A; 1980 Nov; 88(6):377-82. PubMed ID: 7010916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gammopathies.
    Cassuto JP; Hammou JC; Pastorelli E; Dujardin P; Masseyeff R
    Biomedicine; 1977 Jul; 27(5):197-9. PubMed ID: 922119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.
    Saeed SM; Stock-Novack D; Pohlod R; Crowley J; Salmon SE
    Blood; 1991 Dec; 78(12):3281-7. PubMed ID: 1742488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell acid phosphatase in multiple myeloma.
    Musto P
    Blood; 1993 Feb; 81(3):869-70. PubMed ID: 8427981
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma cell acid phosphatase activity as prognostic factor in multiple myeloma: relationship to the thymidine-labeling index.
    Boccadoro M; Gallamini A; Fruttero A; Gavarotti P; Redoglia V; Buffa F; Ruá S; Pileri A
    J Clin Oncol; 1985 Nov; 3(11):1503-7. PubMed ID: 4056842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative cytochemical study of some enzymatic activities in normal and myelomatous plasma cells (author's transl)].
    Invernizzi R; Ippoliti G; Cattaneo G; Trpin L; Casirola G; Carnevale-Maffé G; Cordani M
    Haematologica; 1979 Dec; 64(6):726-34. PubMed ID: 161879
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the usefulness of various cytoenzymatic studies in the differential diagnosis of multiple myeloma and plasmacytic reaction of bone marrow].
    Mariańska B; Maj S; Apel D; Płachecka M
    Acta Haematol Pol; 1985; 16(3-4):117-21. PubMed ID: 3835767
    [No Abstract]   [Full Text] [Related]  

  • 12. Vacuolated plasma cells in multiple myeloma.
    Kanoh T; Yasuda N; Takamatsu T; Uchino H
    Tohoku J Exp Med; 1986 Apr; 148(4):361-4. PubMed ID: 3526637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cell acid phosphatase as an adjunct in the differential diagnosis of monoclonal immunoglobulinemias.
    Tortarolo M; Cantore N; Grande M; Buonanno G; Dammacco F
    Acta Haematol; 1981; 65(2):103-7. PubMed ID: 6785954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytochemistry of plasma cells (author's transl)].
    Miliani A; Anichini P; Pellegrini G; Firorelli C; Cozzolino F
    Haematologica; 1979 Oct; 64 Suppl():35-9. PubMed ID: 161540
    [No Abstract]   [Full Text] [Related]  

  • 15. Cysteamine S-phosphate hydrolysis by pure human alkaline phosphatases and by sera from patients with lymphoproliferative disorders.
    Gainer AL; Stinson RA
    Cancer Res; 1982 Sep; 42(9):3507-9. PubMed ID: 7105027
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma cell acid phosphatase and prognosis in multiple myeloma.
    Musto P; Fusilli S; Carotenuto M
    Leuk Lymphoma; 1994 Aug; 14(5-6):497-501. PubMed ID: 7812211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vacuolated plasma cell: ultrastructural distribution of acid phosphatase and intracellular immunoglobulin.
    Yasuda N; Kanoh T; Uchino H; Ogawa K
    Acta Haematol; 1989; 81(4):203-7. PubMed ID: 2502893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine structural localization of acid phosphatase activity in myeloma cells.
    Miura AB; Suzuki A; Onodera S; Sakamoto S; Suzuki C; Shibata A
    Tohoku J Exp Med; 1968 Dec; 96(4):399-403. PubMed ID: 4180627
    [No Abstract]   [Full Text] [Related]  

  • 19. Telomerase activity in plasma cell dyscrasias.
    Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A
    Br J Cancer; 2001 Mar; 84(5):621-5. PubMed ID: 11237381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytochemistry in the differential diagnosis of patients with a monoclonal component].
    Portero JA; Martín S
    Sangre (Barc); 1984; 29(5):907-12. PubMed ID: 6441293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.